-
PG&E Secures $15 Billion Loan From U.S. Energy Department
The loan, the biggest-ever commitment from the Loan Programs Office, is intended to fund the California utility’s grid and climate resiliency projects.
-
For Years, U.S. Collected Tips About Austin Tice’s Disappearance in Syria
Nongovernmental workers and journalists have scoured prisons for clues about his fate in the absence of an official American presence in the country.
-
A Weary Biden Heads for the Exit
Still stinging from the election, President Biden is pushing for his final priorities but has absented himself from the national conversation about Donald Trump after warning repeatedly that he was a threat to American democracy.
-
Democratic Donors Will Gather to Plot Ways Forward Under Trump
The liberal group American Bridge is planning to bring donors together early next year in Palm Beach, Fla., as the Democratic big-money universe debates what it can do better in 2026 and 2028.
-
After Trump’s Victory, Republicans Trust the Election System Again
Surveys taken since Donald Trump’s win show a resurgent faith among the president-elect’s supporters, and little Democratic appetite for conspiracy theories.
-
George Santos, Disgraced Former Congressman, Still Wants Your Attention
After his lies and expulsion from Congress, and before his sentencing in February, George Santos chases the limelight with a party and a podcast.
-
Oh, the Places We Went!
This year, of the 52 destinations on our annual list, our writers and photographers touched down in 11 to capture their essence. Here’s what they found.
-
Visiting Yellowstone in Winter: 5 Things to Do
Forget the summer crowds, exploring wide-open landscapes by ski, snowmobile or snowshoe, and revel in a solitude that few park visitors ever get to experience.
-
Drugmakers Paid PBMs Not to Restrict Opioid Prescriptions
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.
-
Drugmakers Paid PBMs Not to Restrict Opioid Prescriptions
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.